CardioComm Financial Statements From 2010 to 2024
| EKGGF Stock | USD 0.01 0.00 0.00% |
Check CardioComm Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CardioComm Solutions' main balance sheet or income statement drivers, such as , as well as many indicators such as . CardioComm financial statements analysis is a perfect complement when working with CardioComm Solutions Valuation or Volatility modules.
CardioComm |
CardioComm Solutions Company Current Valuation Analysis
CardioComm Solutions' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current CardioComm Solutions Current Valuation | 1.82 M |
Most of CardioComm Solutions' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CardioComm Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, CardioComm Solutions has a Current Valuation of 1.82 M. This is 99.99% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
CardioComm Solutions Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CardioComm Solutions's current stock value. Our valuation model uses many indicators to compare CardioComm Solutions value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CardioComm Solutions competition to find correlations between indicators driving CardioComm Solutions's intrinsic value. More Info.CardioComm Solutions is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in profit margin category among its peers fabricating about 1.68 of Profit Margin per Return On Asset. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CardioComm Solutions' earnings, one of the primary drivers of an investment's value.About CardioComm Solutions Financial Statements
CardioComm Solutions stakeholders use historical fundamental indicators, such as CardioComm Solutions' revenue or net income, to determine how well the company is positioned to perform in the future. Although CardioComm Solutions investors may analyze each financial statement separately, they are all interrelated. For example, changes in CardioComm Solutions' assets and liabilities are reflected in the revenues and expenses on CardioComm Solutions' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CardioComm Solutions. Please read more on our technical analysis and fundamental analysis pages.
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada. Cardiocom Solutions operates under Health Information Services classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in CardioComm Pink Sheet
CardioComm Solutions financial ratios help investors to determine whether CardioComm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CardioComm with respect to the benefits of owning CardioComm Solutions security.